Odyssean »

Saul Centers shares owned by Odyssean

Quarter-by-quarter ownership of Saul Centers (BFS) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Saul Centers

Tip: Access up to 7 years of quarterly data

All positions including Saul Centers held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Saul Centers by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $445k 12k 37.39

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Saul Centers

BlackRock
Vanguard Portfolio Management
Adage Capital Partners GP
Vanguard Capital Management
State Street Corporation
Principal Financial Group
Geode Capital Management
Morgan Stanley
Ameriprise Financial
Dimensional Fund Advisors
Renaissance Technologies
Invesco
Northern Trust
Charles Schwab Investment Management
Bank of New York Mellon

View all funds holding Saul Centers